8-K - ALX Oncology Holdings Inc. | StockGist

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective Jan

Management Change

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1 2025 Inducement Equity Incentive Plan, as amended on January 21, 2026, and form

Exhibits Only

Exhibits (2)

10.1

EX-10.1

8-K